PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Nature Genetics5 citationsOpen Access

GGC repeat expansions within new open reading frames are translated into toxic polyglycine proteins in oculopharyngodistal myopathy

MBManon BoivinJYJiaxi YuNENobuyuki Eura

Key Points

  • To investigate the pathogenicity of GGC repeat expansions within unrecognized open reading frames associated with oculopharyngodistal myopathy.
  • Identified GGC repeat expansions within new open reading frames in human genomes.
  • Developed antibodies specific to the newly translated polyglycine proteins.
  • Utilized cell, fly, and mouse models to study the effects of polyglycine expression.
  • Tested the cationic porphyrin TMPyP4 for therapeutic potential against polyglycine protein expression.
  • Identified toxic polyglycine proteins generated from GGC repeat expansions.
  • Antibodies stained p62-positive inclusions consistent with the disease pathology.
  • Polyglycine protein expression induced locomotor and skeletal muscle alterations in model organisms.
  • TMPyP4 effectively reduced expression of the toxic proteins, suggesting a promising therapeutic approach.

Abstract

Abstract A total of 3–6% human genome is composed of microsatellite sequences, which are short DNA elements composed of two to six nucleotide motifs repeated in tandem. Expansion of a subset of these microsatellites is the leading cause of >60 diseases. However, most of these mutations are located in sequences annotated as noncoding, which raises questions about their pathogenicity. Here we found that GGC repeat expansions causing oculopharyngodistal myopathy with or without oculopharyngeal myopathy leukoencephalopathy are located within previously unrecognized open reading frames (ORFs), resulting in their translation into new polyglycine-containing proteins. Antibodies developed against these proteins stain the p62-positive inclusions typical of these diseases. Moreover, expression of these polyglycine proteins causes locomotor and skeletal muscle alterations associated with neurodegeneration in cell, fly and mouse models. Finally, we identified a compound, the cationic porphyrin TMPyP4, targeting the expression of these polyglycine proteins, raising hope to develop a therapy for these disorders. Overall, this work highlights the complexity and richness of the human genome and the importance of mutations in yet-unrecognized small ORFs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Boivin et al. (2026) studied this question.

synapsesocial.com/papers/6996a898ecb39a600b3ef7f2https://doi.org/10.1038/s41588-026-02507-z
Ask AI
Helpful
Bookmark
Share
View Full Paper